|Brand names||Elvanse, Venvanse, Vyvanse|
Lisdexamfetamine is a prodrug to dexamfetamine, it was only recently developed for the treatment of ADHD. It, chemically, is composed of the amino acid, L-lysine, bonded to dexamfetamine.[note 1] It is claimed to possess a lower abuse liability than dexamfetamine and other stimulants.
- NCBI Bookshelf provides free book resources on this topic.
- PubMed provides review articles from the past five years (limit to free review articles or to systematic reviews)
- The TRIP database provides clinical publications about evidence-based medicine.
- ↑ This is via the L-lysine's carboxylic acid group bonded with the amine group of the dexamfetamine molecule